J H Meyer1, R Cho, S Kennedy, S Kapur. 1. The Mood and Anxiety Division and PET Centre, The Clarke Division of the Centre for Addictions and Mental Health, Toronto, Ontario, Canada.
Abstract
RATIONALE: Alterations in 5-HT2A receptor binding are implicated in suicidality and depression. 5-HT2A receptors may also be involved in the therapeutic effects of antidepressants. OBJECTIVES: The purpose of this study was to assess the effect of paroxetine and nefazodone on 5-HT2A receptors after a single dose. METHODS: Seven subjects received a single dose of nefazodone 200 mg and five subjects received a single dose of paroxetine 20 mg. Before and after the dose, 5-HT2A binding potentials (Bmax/Kd) were determined in each subject using [18F]-setoperone PET. RESULTS: Nefazodone induced a significant change in 5-HT2A binding potential (-39+/-17%,, P = 0.003) while paroxetine showed no significant alteration of 5-HT2A binding potential (+3+/-13%, P = 0.73). CONCLUSIONS: The change in 5-HT2A binding potential seen with nefazodone represents blockade of 5-HT2A receptors by the drug. We do not find evidence for acute downregulation of 5-HT2A receptors with paroxetine within 9 h.
RATIONALE: Alterations in 5-HT2A receptor binding are implicated in suicidality and depression. 5-HT2A receptors may also be involved in the therapeutic effects of antidepressants. OBJECTIVES: The purpose of this study was to assess the effect of paroxetine and nefazodone on 5-HT2A receptors after a single dose. METHODS: Seven subjects received a single dose of nefazodone 200 mg and five subjects received a single dose of paroxetine 20 mg. Before and after the dose, 5-HT2A binding potentials (Bmax/Kd) were determined in each subject using [18F]-setoperone PET. RESULTS:Nefazodone induced a significant change in 5-HT2A binding potential (-39+/-17%,, P = 0.003) while paroxetine showed no significant alteration of 5-HT2A binding potential (+3+/-13%, P = 0.73). CONCLUSIONS: The change in 5-HT2A binding potential seen with nefazodone represents blockade of 5-HT2A receptors by the drug. We do not find evidence for acute downregulation of 5-HT2A receptors with paroxetine within 9 h.
Authors: Kelly P Cosgrove; Tracy Kloczynski; Nabeel Nabulsi; David Weinzimmer; Shu-Fei Lin; Julie K Staley; Zubin Bhagwagar; Richard E Carson Journal: Synapse Date: 2011-05-03 Impact factor: 2.562
Authors: K Peremans; K Audenaert; Y Hoybergs; A Otte; I Goethals; I Gielen; P Blankaert; M Vervaet; C van Heeringen; R Dierckx Journal: Eur J Nucl Med Mol Imaging Date: 2005-06 Impact factor: 9.236
Authors: Louise M Jørgensen; Pia Weikop; Jonas Villadsen; Tanel Visnapuu; Anders Ettrup; Hanne D Hansen; Anders O Baandrup; Flemming L Andersen; Carsten R Bjarkam; Carsten Thomsen; Bo Jespersen; Gitte M Knudsen Journal: J Cereb Blood Flow Metab Date: 2016-07-20 Impact factor: 6.200
Authors: David Erritzoe; Abhishekh H Ashok; Graham E Searle; Alessandro Colasanti; Samuel Turton; Yvonne Lewis; Mickael Huiban; Sara Moz; Jan Passchier; Azeem Saleem; John Beaver; Anne Lingford-Hughes; David J Nutt; Oliver D Howes; Roger N Gunn; Gitte M Knudsen; Eugenii A Rabiner Journal: Neuropsychopharmacology Date: 2019-11-12 Impact factor: 8.294